As of April 29, 2025, Immuneering (IMRX) has a market cap of $52.618 million USD. According to our data, Immuneering is ranked No.8071 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $52.62 M |
-22.97%
|
Dec 31, 2024 | $68.31 M |
-70.07%
|
Dec 29, 2023 | $0.23 B |
51.55%
|
Dec 30, 2022 | $0.15 B |
-70.01%
|
Dec 31, 2021 | $0.50 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Moderna
MRNA
|
$10.57 B |
-0.043 B
|
![]() USA
|
![]() BioNTech
BNTX
|
$25.00 B |
0.001 M
|
![]() Germany
|
![]() Regeneron Pharmaceuticals
REGN
|
$66.78 B |
1.110 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
![]() USA
|
![]() Amgen
AMGN
|
$152.20 B |
0.126 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.44 B |
-0.001 M
|
![]() USA
|
![]() Novavax
NVAX
|
$1.04 B |
-0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.52 B |
0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$32.98 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.27 B |
2.591 M
|
![]() Switzerland
|
![]() Intellia Therapeutics
NTLA
|
$0.87 B |
-0.000 M
|
![]() USA
|
![]() Editas Medicine
EDIT
|
$0.13 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$40.24 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.000 M
|
![]() USA
|
Market Cap | = | IMRX Stock Price | * | IMRX Shares Outstanding |
= | $1.46 | * | 35.99 M | |
= | $52.62 M |